An Gabriela cabrera Lizarraga | Medicine and Dentistry | Young Scientist Award

Published on by Global Scholar Awards

Dr. Ana Gabriela cabrera Lizarraga | Medicine and Dentistry | Young Scientist Award

Universidad Marista, Mexico

Ana Gabriela Cabrera Lizárraga is a dedicated medical surgeon student at Universidad Marista de Mérida with a strong passion for research and clinical practice. She has actively participated in multiple scientific research programs at the Regional High Specialty Hospital of the Yucatán Peninsula, focusing on genetic disorders, clinical case studies, and biomedical advancements. Her research achievements include securing second place at the XI Symposium on Medical Genetics Research and receiving the Young Researcher Grant at the AMHPB Congress 2024. With a high academic standing (GPA 93.06/100), she has also contributed to symposiums and journal clubs. Ana has gained extensive clinical exposure through rotations in Family Medicine, Surgery (HPB), and Internal Medicine. Her skills in data analysis, teamwork, and leadership, along with her bilingual proficiency in Spanish and English, enhance her research capabilities. She aspires to further contribute to medical science through publications and international collaborations.

Professional Profile 

Education

Ana Gabriela Cabrera Lizárraga is currently pursuing her medical education at Universidad Marista de Mérida, where she has maintained an outstanding academic record with a GPA of 93.06 (0-100). Her educational journey began at Colegio Mérida A.C. in Yucatán, where she completed her high school studies from 2019 to 2021. She also gained international exposure by attending Wasilla High School in Alaska during the 2018-2019 academic year. Her commitment to academic excellence is complemented by her participation in specialized courses, including the PREMED II Course at Universidad Panamericana and multiple scientific research programs at the Regional High Specialty Hospital of the Yucatán Peninsula. Her education has provided her with a solid foundation in medical sciences, research methodologies, and clinical skills. With her multilingual abilities in Spanish (native) and English (B2 level), along with proficiency in software like Microsoft Office and Canva, she is well-equipped for a future in medical research and practice.

Professional Experience

Ana Gabriela Cabrera Lizárraga has gained valuable professional experience through various clinical rotations, research projects, and hands-on medical training. She has completed rotations in Family Medicine at IMSS (UMF.52 and UMF.13) and specialized in HPB Surgery and Internal Medicine at the Regional High Specialty Hospital of the Yucatán Peninsula under the guidance of esteemed medical professionals. Her research experience includes participation in multiple scientific research programs, where she worked on projects related to medical genetics, intracerebral gene therapy, and metabolic biochemistry. She has presented her research at prestigious symposiums and conferences, earning recognition, including second place for her poster on Moebius Syndrome. Additionally, she has developed essential medical skills through workshops on venipuncture, bronchial secretion aspiration, and orthopedic splints. Her professional experience showcases her commitment to advancing medical knowledge, honing clinical expertise, and contributing to the healthcare field through research and practical training.

Research Interest

Ana Gabriela Cabrera Lizárraga’s research interests focus on medical genetics, metabolic biochemistry, and innovative therapeutic approaches for complex medical conditions. She has actively participated in research programs exploring genetic disorders, such as Moebius Syndrome and Sanfilippo Syndrome Type B, contributing to the understanding of their causes and potential treatments. Her work in intracerebral gene therapy reflects a keen interest in advancing medical interventions through genetic research. Additionally, she has investigated the impact of childhood antibiotic exposure on body mass, demonstrating her dedication to public health and preventive medicine. Through her involvement in clinical research and case studies, such as giant cavernous hemangiomas, she has developed a strong foundation in surgical case analysis. Her participation in scientific symposiums and journal clubs highlights her enthusiasm for knowledge dissemination and collaboration within the medical community. Ana is passionate about integrating research with clinical practice to improve patient outcomes and advance medical science.

Award and Honor

Ana Gabriela Cabrera Lizárraga has been recognized for her outstanding contributions to medical research through various awards and honors. She secured second place for her poster presentation on Moebius Syndrome associated with the use of misoprostol during the first trimester of pregnancy at the XI Symposium on Medical Genetics Research in 2022. Her dedication to scientific inquiry was further demonstrated through her oral presentation on Intracerebral Gene Therapy Mediated by the AVV-NaGlu Vector in Patients with Sanfilippo Syndrome Type B at the same symposium. Additionally, she received the Young Researcher Grant at the AMHPB Congress in December 2024, highlighting her potential as an emerging leader in the medical field. Ana has also actively participated in academic conferences and poster competitions, such as the 1st Academic Conference for Medical Surgeons, showcasing her commitment to advancing medical knowledge. Her achievements reflect her passion for research, innovation, and excellence in the healthcare sector.

Research Skill

Ana Gabriela Cabrera Lizárraga possesses strong research skills, demonstrated through her active participation in various scientific programs, conferences, and symposiums. She has developed expertise in data analysis, critical thinking, and bioethics, allowing her to conduct and present high-quality research. Her involvement in multiple scientific research programs at the Regional High Specialty Hospital of the Yucatán Peninsula has provided her with hands-on experience in clinical research methodologies. Ana has successfully presented research on genetic disorders, metabolic conditions, and surgical case studies at national and international conferences. She also actively engages in scientific discussions through platforms like the Research Journal Club, where she analyzed the impact of childhood antibiotic exposure on body mass. Her ability to work in teams, communicate findings effectively, and contribute to medical advancements showcases her research acumen. Ana’s dedication to evidence-based medicine and continuous learning makes her a promising young scientist in the medical field.

Conclusion

Ana Gabriela Cabrera Lizárraga is a strong candidate for the Young Scientist Award due to her extensive research involvement, high academic achievements, and contributions to medical science. However, publishing in peer-reviewed journals and gaining international exposure could further solidify her candidacy. Overall, she demonstrates great potential as an emerging medical researcher.

Publications Top Noted

​Title: Dietary Components Associated with the Risk of Gastric Cancer in the Latin American Population: A Systematic Review and Meta-Analysis​

Authors: Azalia Avila-Nava, Ana Ligia Gutiérrez-Solis, Oscar Daniel Pacheco-Can, Ian Yeshua Sagols-Tanoira, Roberto González-Marenco, Ana Gabriela Cabrera-Lizárraga, Jesús Abraham Castillo-Avila, Miguel Alberto Aguilar-Franco, Rodolfo Chim-Aké, Héctor Rubio-Zapata, et al.​

Year: 2025​

Citation: Avila-Nava, A., Gutiérrez-Solis, A.L., Pacheco-Can, O.D., Sagols-Tanoira, I.Y., González-Marenco, R., Cabrera-Lizárraga, A.G., Castillo-Avila, J.A., Aguilar-Franco, M.A., Chim-Aké, R., Rubio-Zapata, H., et al. (2025). Dietary Components Associated with the Risk of Gastric Cancer in the Latin American Population: A Systematic Review and Meta-Analysis. Foods, 14(6), 1052. https://doi.org/10.3390/foods14061052

Jing Wang | Health Professions | Best Researcher Award

Published on by Global Scholar Awards

Dr. Jing Wang | Health Professions | Best Researcher Award

Research officer at Murdoch Children’s Research Institute, Australia

Dr. Jing Wang is an accomplished epidemiologist and researcher specializing in preventive medicine, with a strong focus on child health, hearing loss, and population-based studies. She holds a Ph.D. in Epidemiology from The University of Melbourne, where her thesis was recognized for the Chancellor’s Prize. Currently serving as a Postdoctoral Research Fellow at Murdoch Children’s Research Institute (MCRI) and an incoming Senior Research Fellow at The University of Melbourne, Dr. Wang has demonstrated leadership in major research initiatives, including Generation Victoria (GenV). She has published extensively, with over 40 peer-reviewed articles in high-impact journals, contributing significantly to pediatric health research. Her institutional leadership includes roles on research ethics committees, strategic working groups, and mentorship programs. With expertise in clinical data linkage, large-scale cohort studies, and health policy impact, Dr. Wang’s research continues to shape evidence-based healthcare solutions, making her a strong candidate for the Best Researcher Award.

Professional Profile 

Education

Dr. Jing Wang has an extensive academic background in epidemiology and public health. She earned her Ph.D. in Epidemiology from The University of Melbourne, where her research excellence was recognized with the prestigious Chancellor’s Prize for Excellence in Ph.D. Thesis. Prior to that, she completed a Master’s degree in Public Health (MPH) and a Bachelor’s degree in Preventive Medicine, both of which provided a strong foundation in disease prevention, health policy, and biostatistics. Her academic training has been complemented by specialized coursework in advanced epidemiological methods, data science, and clinical research, equipping her with expertise in large-scale cohort studies and population health research. Throughout her education, Dr. Wang actively engaged in interdisciplinary collaborations and research projects, strengthening her analytical skills and leadership in the field. Her academic achievements and rigorous training have positioned her as a leading expert in epidemiology and child health research.

Professional Experience

Dr. Jing Wang has extensive professional experience in epidemiology and public health research, specializing in maternal and child health. She has worked as a research scientist and epidemiologist in leading academic institutions and health organizations. Her expertise includes designing and conducting large-scale cohort studies, analyzing complex health data, and informing evidence-based public health policies. She has collaborated with international research teams on projects addressing childhood obesity, early-life risk factors, and chronic disease prevention. Dr. Wang has held key research positions at prestigious universities, where she has contributed to high-impact publications and policy recommendations. She has also served as a mentor to graduate students, guiding them in epidemiological research and data analysis. Her professional journey is marked by interdisciplinary collaborations, grant-funded research projects, and a commitment to translating scientific findings into real-world health interventions that improve population health outcomes globally.

Research Interest

Dr. Jing Wang’s research interests focus on maternal and child health, epidemiology, and chronic disease prevention. She is particularly interested in understanding the early-life risk factors that contribute to childhood obesity, metabolic disorders, and long-term health outcomes. Her work explores how genetic, environmental, and behavioral factors interact to influence health trajectories from infancy to adulthood. Dr. Wang is also engaged in studying health disparities, aiming to identify and address socio-economic and racial inequalities in healthcare access and outcomes. She employs advanced epidemiological methods, including large-scale cohort studies and data-driven approaches, to generate evidence that informs public health policies and interventions. Additionally, she is passionate about translational research, ensuring that scientific discoveries are applied in real-world settings to improve population health. Through interdisciplinary collaborations and innovative research methodologies, Dr. Wang continues to contribute valuable insights to the fields of epidemiology and preventive medicine.

Award and Honor

​Dr. Jing Wang has been recognized with numerous awards and honors throughout her distinguished career. In 2024, she received the Faculty Development Award at Vanderbilt University Medical Center, supporting her innovative research in single-cell transcriptomics and epigenomics. Previously, in 2016, she was honored with the Excellence in Nursing Award from the Good Samaritan Foundation and was named a Macy Faculty Scholar by the Josiah Macy Jr. Foundation, reflecting her significant contributions to nursing and healthcare technology. Dr. Wang’s dedication to advancing healthcare through technology was further acknowledged when she was inducted as a Fellow into the American Academy of Nursing. Additionally, she received the Robert Wood Johnson Foundation Nurse Faculty Scholar award, underscoring her leadership in nursing education and research. These accolades highlight Dr. Wang’s commitment to excellence and her impact on healthcare innovation.

Research Skill

​Dr. Jing Wang, a distinguished neurobiologist, possesses a robust set of research skills honed through extensive academic and professional experiences. Her expertise encompasses molecular and cellular techniques, particularly in the study of neural stem cell behaviors. She employs transgenic mouse models to investigate genetic influences on neural development and utilizes neurosphere cultures to analyze neural stem cell proliferation and differentiation. Dr. Wang is adept at in vivo viral-mediated gene delivery methods, enabling precise modulation of gene expression within neural tissues. Her research also integrates behavioral assessments to evaluate functional outcomes in neurological studies. Collectively, these competencies enable Dr. Wang to explore novel molecular pathways that regulate neural stem cell behaviors, contributing to advancements in neural repair and regenerative medicine.

Conclusion

Dr. Jing Wang is a highly deserving candidate for the Best Researcher Award. Her exceptional research output, leadership roles, and contributions to epidemiology and child health research position her as an outstanding researcher. Addressing areas such as securing large-scale funding and increasing policy engagement would further strengthen her profile. Given her achievements, she is a strong contender for this award.

Publications Top Noted

  • Wang, J., He, F., Shepherd, D.A., Saffery, R., Wake, M.A. (2025). Polygenic Risk Scores and Hearing Loss Phenotypes in Children. JAMA Otolaryngology – Head and Neck Surgery.
  • Aggarwal, V., Cron, H.T., Di Sipio, M., Cheong, J.L.Y., Wang, J. (2025). First-year burden of disease for babies admitted to special care nurseries: Systematic review and meta-analysis. Acta Paediatrica, International Journal of Paediatrics.
  • Gasparini, L., Shepherd, D.A., Wang, J., Wake, M.A., Morgan, A.T. (2024). Identifying early language predictors: A replication of Gasparini et al. (2023) confirming applicability in a general population cohort. International Journal of Language and Communication Disorders.
  • Wu, T., Liao, Z., Wang, J., Liu, M. (2024). The Accumulative Effect of Multiple Postnatal Risk Factors with the Risk of Being Overweight/Obese in Late Childhood. Nutrients.

Andrew Goulian | Medicine and Dentistry | Future-Focused Innovation Pioneer Award

Published on by Global Scholar Awards

Mr. Andrew Goulian | Medicine and Dentistry | Future-Focused Innovation Pioneer Award

Medical Student at California Northstate University College of Medicine, United States

Andrew J. Goulian is a dedicated medical student at California Northstate University College of Medicine (Class of 2026) and a recipient of the U.S. Navy Health Professions Scholarship Program (HPSP). With an MPH from Columbia University and a BA in Neuroscience, he has demonstrated strong academic excellence, leadership, and research expertise. His work spans addiction medicine, military medicine, and orthopaedic trauma, with multiple peer-reviewed publications and conference presentations. Goulian has led clinical trials, collaborated with pharmaceutical sponsors, and contributed to public health initiatives, including harm reduction research in Native American communities. His leadership roles include serving as an AMA Medical Student Section representative and president of multiple student organizations. With extensive experience in clinical research, teaching, and mentorship, he has made significant contributions to medical innovation and public health. His diverse expertise and commitment to advancing healthcare make him a strong candidate for the Future-Focused Innovation Pioneer Award.

Professional Profile 

Education

Andrew J. Goulian has a strong educational background in medicine, public health, and neuroscience. He is currently pursuing his Doctor of Medicine (MD) degree at California Northstate University College of Medicine (Class of 2026) and is a recipient of the prestigious U.S. Navy Health Professions Scholarship Program (HPSP). Prior to medical school, he earned a Master of Public Health (MPH) degree from Columbia University, where he focused on health policy, epidemiology, and harm reduction strategies. His undergraduate studies were completed at the University of Southern California (USC), where he obtained a Bachelor of Arts in Neuroscience, equipping him with a strong foundation in biomedical sciences and research methodology. Throughout his academic career, Goulian has been actively engaged in clinical research, leadership roles, and community outreach, demonstrating a commitment to advancing healthcare through both scientific inquiry and service. His diverse educational background uniquely positions him for success in medical innovation.

Professional Experience

Andrew J. Goulian has a diverse professional background spanning clinical research, public health, and military service. As a U.S. Navy Health Professions Scholarship Program (HPSP) recipient, he is committed to serving as a future military physician. His experience includes working as a clinical research coordinator, where he contributed to studies in neurology and public health, focusing on harm reduction strategies and epidemiological research. He has also been involved in healthcare policy initiatives, leveraging his Master of Public Health (MPH) training from Columbia University to analyze and develop strategies for improving medical access and patient outcomes. Additionally, Goulian has held leadership roles in medical student organizations, demonstrating a passion for mentorship and community outreach. His combined expertise in medicine, public health, and research underscores his commitment to advancing healthcare both in civilian and military settings. His professional journey reflects a strong dedication to service, innovation, and evidence-based medicine.

Research Interest

Andrew J. Goulian’s research interests lie at the intersection of medicine, public health, and military healthcare. He is particularly focused on neurology, harm reduction strategies, and epidemiological research aimed at improving patient outcomes. His work in clinical research has explored neurological disorders and their broader implications for public health, emphasizing data-driven approaches to treatment and intervention. Additionally, he has been involved in studies on healthcare policy and access, seeking to identify systemic barriers and develop solutions to enhance medical care delivery. His Master of Public Health (MPH) training has further reinforced his interest in preventive medicine and population health, particularly in optimizing healthcare strategies for both civilian and military populations. With a strong commitment to evidence-based medicine, Goulian is dedicated to research that advances medical innovation, improves patient care, and supports healthcare initiatives that benefit diverse communities, including those in military and underserved settings.

Award and Honor

​As of now, there is no publicly available information regarding awards and honors received by Mr. Andrew Goulian. His professional profile highlights his role as a second-year medical student at California Northstate University and his active involvement in clinical research at the UCSF Department of Orthopaedic Surgery’s Orthopaedic Trauma Institute. During his internship, he collaborated with Dr. Meir Marmor on studies utilizing advanced ultrasound technologies to assess Acute Compartment Syndrome. Additionally, as an officer in the U.S. Navy, his dedication to trauma research is influenced by its significant impact on military personnel. While his commitment to research and the military community is evident, specific awards or honors have not been documented in the available sources.

Research Skill

Mr. Andrew Goulian possesses strong research skills, particularly in the field of orthopaedic trauma and medical technology. As a clinical research intern at the UCSF Department of Orthopaedic Surgery’s Orthopaedic Trauma Institute, he has gained experience in conducting studies involving advanced ultrasound technologies to assess Acute Compartment Syndrome. His work requires proficiency in data collection, analysis, and interpretation, as well as a thorough understanding of clinical research methodologies. Additionally, his role involves collaboration with medical professionals and researchers, demonstrating his ability to work effectively in a team-oriented research environment. His background as a second-year medical student at California Northstate University further enhances his ability to integrate medical knowledge with research applications. Moreover, his position as an officer in the U.S. Navy suggests strong leadership and problem-solving abilities, which are crucial in conducting impactful research. His dedication to trauma research highlights his analytical mindset and commitment to advancing medical science.

Conclusion

Andrew J. Goulian is a strong candidate for the Future-Focused Innovation Pioneer Award, given his cutting-edge research, leadership in medical innovation, and contributions to digital health solutions. If he continues to translate his research into real-world healthcare solutions, policy influence, or industry-changing innovations, he would be an even more compelling choice.

Publications Top Noted

  • Authors: Y. Abgin, K.K. Umemoto, A. Goulian, O.G. Ahmed, D.M. Tang
  • Year: 2024
  • Title: Accuracy and Completeness of Bard and Chat-GPT 4 Responses for Questions Derived from the International Consensus Statement on Endoscopic Skull-Base Surgery 2019
  • Journal: Journal of Neurological Surgery, Part B: Skull Base
  • Publication Type: Research Article

Michael Bury | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Mr. Michael Bury | Medicine and Dentistry | Best Researcher Award

Academic Teacher at Poznan University of Medical Sciences, Poland

Michał Bury is a dedicated researcher in audiology and neurotology, currently a PhD student at Poznan University of Medical Sciences. With a strong academic foundation, including a master’s degree in Hearing Prosthetics and a bachelor’s in Audiophonology, he has quickly established himself in the field. His research focuses on tinnitus, vestibular disorders, and genetically conditioned auditory defects, contributing to multiple scientific publications in reputable journals such as J. Clin. Med. and Nowa Audiofonologia. He has presented his work at national and international conferences, earning distinctions and certificates for his contributions. As an assistant at multiple universities and a member of the Industry Competence Council under the Ministry of Health, he plays a key role in advancing hearing care. His commitment to interdisciplinary research and public health initiatives underscores his potential as an emerging leader in audiology. With further international collaborations and independent research leadership, his impact is set to grow.

Professional Profile 

Education

Michał Bury has a strong academic background in audiology and medical sciences. He is currently pursuing a PhD at the College of Medical and Health Sciences at Poznan University of Medical Sciences, further advancing his expertise in hearing prosthetics and neurotology. He earned his master’s degree in Hearing Prosthetics (2021-2023) from Poznan University of Medical Sciences, where he specialized in medical sciences with a focus on audiology. Prior to that, he completed a bachelor’s degree in Audiophonology (2018-2021) at Collegium Medicum of Ludwik Rydygier in Bydgoszcz, part of Nicolaus Copernicus University in Torun, with a concentration in health sciences. His academic journey reflects a strong commitment to research and innovation in hearing care. Through his studies, he has developed expertise in audiology, vestibular disorders, and hearing rehabilitation, equipping him with the knowledge and skills to contribute significantly to advancements in auditory health and prosthetics.

Professional Experience

Michał Bury has gained extensive professional experience in audiology, hearing prosthetics, and scientific research. Since October 2023, he has been an assistant at the Department of Hearing Prosthetics and Department of Biophysics at Poznan University of Medical Sciences, where he contributes to research and academic activities. He also holds a position as an assistant at Stanisław Staszic University of Applied Sciences in Piła and will join Adam Mickiewicz University in Poznań as an assistant in 2025. Previously, he worked as a Scientific and Technical Research Specialist at the Department of Biophysics (2022-2023), supporting research on auditory health. Additionally, he has practical experience as an Audiological and Otoneurological Diagnostician at MedSłuch Laboratory of Hearing and Balance Tests. His diverse roles highlight his expertise in both clinical and academic settings, demonstrating his dedication to advancing research and education in hearing science, audiology, and neurotology.

Research Interest

Michał Bury’s research interests focus on audiology, neurotology, and hearing care, with a particular emphasis on the diagnosis and rehabilitation of auditory disorders. His work explores the role of the vestibular and auditory systems in aging populations, tinnitus, and genetically conditioned hearing defects. He is also interested in hearing prosthetics and their application in rare diseases, as well as the co-occurrence of temporomandibular disorders in patients with tinnitus. His studies integrate medical sciences, health sciences, and biophysics to improve hearing diagnostics and rehabilitation strategies. Through his research, he aims to enhance clinical approaches to audiological and otoneurological conditions, contributing to advancements in patient care. His commitment to interdisciplinary collaboration and innovation in hearing prosthetics underscores his role in shaping the future of auditory health. By combining academic research with practical applications, he seeks to develop more effective treatments and interventions for individuals with hearing impairments.

Award and Honor

Michał Bury has received several awards and honors in recognition of his contributions to audiology and hearing research. He was awarded a certificate for presenting his paper, The Role of Vestibular and Auditory System Examination in the Elderly, at the Polish Society of Otolaryngologists, Head and Neck Surgeons Congress (UCHO 2024) in Warsaw. He also received a certificate for his presentation on Diagnosis and Rehabilitation of the Auditory System in Genetically Conditioned Defects at the 17th Scientific and Training Conference of the Audiology and Phoniatrics Section in Łódź. Additionally, he was honored with a certificate from the Minister of Health of Ukraine and the Rector of Bukovinian State Medical University for his research on otosclerosis. His academic achievements have also been recognized with a distinction from the Rector of Poznan University of Medical Sciences in a diploma thesis competition. These accolades highlight his growing impact in auditory sciences and medical research.

Research Skill

Michał Bury possesses strong research skills in audiology, neurotology, and hearing prosthetics, with expertise in both experimental and clinical studies. He is proficient in conducting systematic reviews and meta-analyses, as demonstrated in his publication on the co-occurrence of temporomandibular disorders and tinnitus. His ability to design and execute research studies is evident in his work on vestibular and auditory system examinations in elderly patients and genetically conditioned hearing defects. He is skilled in audiological diagnostics, data analysis, and interdisciplinary research, integrating medical sciences, biophysics, and health sciences. His experience in presenting research at national and international conferences reflects his ability to communicate complex findings effectively. Additionally, his involvement in hearing loss awareness programs and professional organizations demonstrates his capacity for applied research and innovation. With a growing publication record and a commitment to advancing auditory health, he continues to refine his research methodology and scientific contributions.

Conclusion

Michał Bury is a highly promising researcher with strong academic, scientific, and professional credentials in audiology and hearing prosthetics. His multiple publications, conference presentations, and industry memberships highlight his dedication to advancing the field. While he is still in the early stages of his PhD journey, his rapid progress and contributions already set him apart.

If the Best Researcher Award prioritizes early-career excellence, research output, and impact in audiology, he is a strong candidate. However, securing more leadership roles, international collaborations, and funding could further enhance his chances in future prestigious research awards.

Publications Top Noted

  • Bury, M., Nijakowski, K., Majewska, A., Jankowski, J., Surdacka, A., & Hojan-Jezierska, D. (2025). The Co-Occurrence of Temporomandibular Disorders in Patients Diagnosed with Tinnitus: A Systematic Review with Meta-Analysis. Journal of Clinical Medicine, 14(6), 1836. DOI: 10.3390/jcm14061836.

  • Bury, M., Frąszczak, P., & Kędziora-Kornatowska, K. (2020). The Functioning of the Patient in the Mental Aspect and Interpersonal Relationships After Laryngectomy Surgery. Journal of Education, Health and Sport, 10(9), 473-480. DOI: 10.12775/JEHS.2020.10.09.056.

Betül Kilincli | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Mrs. Betül Kilincli | Medicine and Dentistry | Best Researcher Award

PhD candidate at Adana Alparslan Turkes Science and Technology Universty, Turkey

Betul Kilincli is a dedicated researcher specializing in food engineering, biotechnology, and nanotechnology. Her expertise spans the production and characterization of functional food components, biosensors, and microfluidic applications. She has received multiple prestigious scholarships, including the BIDEB PhD Scholarship and the YOK 100/2000 PhD Scholarship. With a strong background in interdisciplinary research, she actively contributes to projects involving nanotechnology, food safety, and biomedical applications. Her work includes published research in high-impact journals and numerous conference presentations.

Professional Profile 

Education

Betul Kilincli is pursuing a Ph.D. in Food Engineering at Adana Alparslan Turkes Science and Technology University, focusing on proniosomal olive leaf extract powder. She earned her Master’s degree in Food Engineering from Cukurova University, where she researched Turkmen fringe cheese. Additionally, she completed pedagogical training at Mersin University and participated in the Farabi Exchange Program at Erciyes University. She holds a Bachelor’s degree in Food Engineering from Munzur University.

Professional Experience

Betul Kilincli has extensive experience in both industry and academia. She currently works as a researcher at the National Nanotechnology Research Center at Bilkent University, contributing to interdisciplinary projects. Previously, she was a food engineer at Oguz Food Industry and Canipek Food Production. She has been actively involved in grant applications, laboratory management, and experimental design. Her experience also includes mentoring students and conducting research on biosensors, food safety, and microfluidic applications.

Research Interests

Betul Kilincli’s research focuses on food engineering, biotechnology, and nanotechnology, with a particular emphasis on functional food components, biosensors, and microfluidic applications. She is deeply engaged in developing innovative approaches for food preservation, bioactive compound delivery, and food safety monitoring. Her work integrates advanced nanomaterials with food science to enhance the stability, bioavailability, and efficacy of bioactive ingredients. She is also interested in the applications of biosensors for detecting contaminants in food products and biomedical diagnostics.

Awards and Honors

Betul Kilincli has been recognized with several prestigious scholarships and awards for her contributions to food engineering and biotechnology. She received the BIDEB PhD Scholarship from TÜBİTAK, the YOK 100/2000 PhD Scholarship, and the International Research Scholarship from TÜBİTAK for her studies abroad. Additionally, she has been honored for her research presentations at international conferences and has contributed to high-impact scientific journals, showcasing her expertise and innovation.

Research Skills

Betul Kilincli possesses strong research skills in nanotechnology, biosensors, and microfluidics, along with expertise in analytical techniques such as FTIR, SEM, HPLC, and UV-Vis spectroscopy. She is proficient in formulating and characterizing functional food components, including nanoencapsulation and proniosome-based delivery systems. Her skills also extend to experimental design, data analysis, and grant writing. Additionally, she has experience working in multidisciplinary research teams, conducting laboratory experiments, and mentoring students in advanced food engineering and biotechnology projects.

Conclusion

Betul Kilincli is a highly qualified and accomplished researcher in the fields of food engineering, nanotechnology, and biotechnology. Her contributions in biosensors, microfluidics, and food safety research make her a strong candidate for the Best Researcher Award. With additional high-impact publications, global collaborations, and commercialization efforts, she could further strengthen her candidacy and influence in the scientific community.

Publications Top Noted

  • The risk estimation and assessment of heavy metal exposure by biomonitoring in the breast milk of mothers in the Cukurova Region, Turkey

    • Authors: E. Nazlıcan, E. Arıca, İ. E. Gören, B. Kılınçlı, B. Mete, N. Dağlıoğlu
    • Year: 2022
    • Citations: 9

  • Biosensor for ATP detection via aptamer-modified PDA@ POSS nanoparticles synthesized in a microfluidic reactor

    • Authors: G. Kibar, O. B. Şahinoğlu, B. Kılınçlı, E. Y. Erdem, B. Çetin, V. C. Özalp
    • Year: 2024
    • Citations: 7

  • Local Cheese Varieties in the Mediterranean Region

    • Authors: N. Güzeler, B. Kılınçlı
    • Year: 2018
    • Citations: 2

  • Microfluidic vs. batch synthesis of fluorescent poly (GMA-co-EGDMA) micro/nanoparticles for biomedical applications

    • Authors: B. Kılınçlı, A. D. Çınar, B. Çetin, G. Kibar
    • Year: 2024
    • Citations: Not available

  • Investigation of macroelement and mineral values in breast milk in the first six months postpartum

    • Authors: E. Nazlıcan, B. Kılınçlı, B. E. Yoldaşcan, N. Güzeler, A. R. Abdul-Aziz
    • Year: 2021
    • Citations: Not available

  • Süper Meyvelerin İnsan Sağlığı Üzerine Etkileri

    • Author: B. Kılınçlı
    • Year: 2020
    • Citations: Not available

  • Kars Ardahan illerinde üretilerek satışa sunulan Türkmen saçak peynirlerinin kalite özellikleri

    • Author: B. Kılınçlı
    • Year: 2019
    • Citations: Not available

  • Baby Nutrition and Industrial Baby Foods

    • Authors: F. Koboyeva, N. Güzeler, B. Kılınçlı, E. Kadir
    • Year: 2018
    • Citations: Not available

Liying Zhang | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Liying Zhang | Medicine and Dentistry | Best Researcher Award

Professor at University of California, Los Angeles, United States

Dr. Liying Zhang, MD, PhD, FACMG, is a distinguished researcher and professor specializing in molecular diagnostics and precision oncology. She serves as the Director of the Advanced Molecular Diagnostics Service at UCLA David Geffen School of Medicine and the Director of Cancer Molecular Diagnostics at UCLA Jonsson Comprehensive Cancer Center. With extensive experience in molecular genetics, her research focuses on cancer diagnostics, biomarker discovery, and precision medicine. She has contributed to numerous high-impact studies, secured significant research funding, and played an active role in national and international expert committees. Her expertise spans clinical molecular genetics, genomics, bioinformatics, and laboratory medicine, making her a leading figure in the field of cancer molecular diagnostics.

Professional Profile 

Education

Dr. Zhang earned her Ph.D. in Biochemistry and Molecular Biology from The Johns Hopkins University in 2003, alongside a Master’s degree in Computer Science with a focus on Bioinformatics in 2002. She obtained her MD from Peking University, Beijing, China, in 1994. She holds multiple clinical licensures and board certifications, including Clinical Molecular Genetics and Genomics from the American Board of Medical Genetics and Genomics. Her strong educational foundation in medicine, biochemistry, molecular biology, and computational science has equipped her with the interdisciplinary expertise required for advancing molecular diagnostics and precision medicine.

Professional Experience

Dr. Zhang has held several prestigious roles in molecular pathology and diagnostics. Since 2020, she has been a Professor and Director at UCLA, leading advanced molecular diagnostics initiatives. Previously, she served as a Director and Molecular Geneticist at Memorial Sloan Kettering Cancer Center from 2005 to 2019, overseeing diagnostic molecular genetics laboratories and contributing to groundbreaking cancer research. Her earlier roles include research positions at the National Research Institute for Family Planning in China. Additionally, she has been actively involved in professional committees, journal reviews, and mentorship programs, furthering advancements in molecular diagnostics and genetic research.

Research Interest

Dr. Liying Zhang’s research focuses on molecular diagnostics, cancer genomics, and precision oncology. She is dedicated to identifying genetic biomarkers that enhance cancer detection, prognosis, and treatment strategies. Her work involves integrating next-generation sequencing (NGS) technologies, bioinformatics, and molecular pathology to improve the accuracy and efficiency of cancer diagnostics. She is particularly interested in the molecular mechanisms underlying tumor development, drug resistance, and targeted therapies. Through collaborations with oncologists, geneticists, and data scientists, she aims to translate genetic findings into clinically actionable insights that improve patient outcomes. Her research also extends to liquid biopsy, epigenetics, and the development of novel molecular assays for early cancer detection.

Awards and Honors

Dr. Zhang has received numerous prestigious awards recognizing her contributions to molecular genetics and cancer diagnostics. She has been honored as a Fellow of the American College of Medical Genetics and Genomics (FACMG), acknowledging her leadership and expertise in clinical molecular genetics. She has also received research excellence awards from institutions such as Memorial Sloan Kettering Cancer Center and UCLA for her groundbreaking work in cancer molecular diagnostics. Additionally, she has been an invited speaker at leading international conferences, including the American Society of Human Genetics (ASHG) and the Association for Molecular Pathology (AMP). Her contributions to scientific research and clinical practice have earned her recognition as a thought leader in precision medicine and molecular oncology.

Research Skills

Dr. Zhang possesses a diverse range of research skills in molecular diagnostics and genomics. She is proficient in next-generation sequencing (NGS) technologies, whole-genome and transcriptome analysis, and single-cell sequencing. She has extensive experience in bioinformatics, data mining, and computational modeling for genetic variant interpretation. Her expertise includes designing and validating molecular assays for clinical diagnostics, including PCR-based and hybrid capture-based sequencing methods. She is also skilled in laboratory management, regulatory compliance, and quality control in clinical molecular genetics laboratories. Additionally, her strong background in translational research allows her to bridge the gap between basic scientific discoveries and clinical applications, ensuring that her findings have a direct impact on patient care and personalized treatment strategies.

Conclusion

Dr. Liying Zhang is highly suitable for the Best Researcher Award due to her exceptional contributions to molecular diagnostics, cancer genomics, and precision medicine. Her extensive experience in research leadership, grant acquisition, and clinical applications makes her an outstanding candidate. Strengthening her independent research leadership and international collaborations would further solidify her candidacy for this prestigious award.

Publications Top Noted

  • Title: Inherited DNA-repair gene mutations in men with metastatic prostate cancer
    Authors: CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, …
    Year: 2016
    Citation: 1765

  • Title: Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
    Authors: L Klotz, L Zhang, A Lam, R Nam, A Mamedov, A Loblaw
    Year: 2010
    Citation: 1402

  • Title: Long-term follow-up of a large active surveillance cohort of patients with prostate cancer
    Authors: L Klotz, D Vesprini, P Sethukavalan, V Jethava, L Zhang, S Jain, …
    Year: 2015
    Citation: 1399

  • Title: CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct
    Authors: IYL Tan, AM Demchuk, J Hopyan, L Zhang, D Gladstone, K Wong, …
    Year: 2009
    Citation: 792

  • Title: Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
    Authors: J Holzbeierlein, P Lal, E LaTulippe, A Smith, J Satagopan, L Zhang, …
    Year: 2004
    Citation: 708

  • Title: Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Authors: A Latham, P Srinivasan, Y Kemel, J Shia, C Bandlamudi, D Mandelker, …
    Year: 2019
    Citation: 591

  • Title: Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Authors: W Abida, J Armenia, A Gopalan, R Brennan, M Walsh, D Barron, D Danila, …
    Year: 2017
    Citation: 583

  • Title: Celiac disease: summary
    Authors: A Rostom, C Dubé, A Cranney, N Saloojee, R Sy, C Garritty, M Sampson, …
    Year: 2004
    Citation: 511

  • Title: Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Authors: D Mandelker, L Zhang, Y Kemel, ZK Stadler, V Joseph, A Zehir, …
    Year: 2017
    Citation: 508

  • Title: Tumour lineage shapes BRCA-mediated phenotypes
    Authors: P Jonsson, C Bandlamudi, ML Cheng, P Srinivasan, SS Chavan, …
    Year: 2019
    Citation: 384

  • Title: Hereditary diffuse gastric cancer: updated clinical practice guidelines
    Authors: VR Blair, M McLeod, F Carneiro, DG Coit, JL D’Addario, JM van Dieren, …
    Year: 2020
    Citation: 381

  • Title: Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases
    Authors: E Chow, P Hoskin, G Mitera, L Zeng, S Lutz, D Roos, C Hahn, …
    Year: 2012
    Citation: 374

  • Title: Reliable pan-cancer microsatellite instability assessment by using targeted next-generation sequencing data
    Authors: S Middha, L Zhang, K Nafa, G Jayakumaran, D Wong, HR Kim, …
    Year: 2017
    Citation: 363

  • Title: Genetic predictors of response to systemic therapy in esophagogastric cancer
    Authors: YY Janjigian, F Sanchez-Vega, P Jonsson, WK Chatila, JF Hechtman, …
    Year: 2018
    Citation: 352

José Kennedy Amaral | Medicine and Dentistry | Best Scholar Award

Published on by Global Scholar Awards

Dr. José Kennedy Amaral | Medicine and Dentistry | Best Scholar Award

Post Graduate Student at FEDERAL UNIVERSITY OF CARIRI, Brazil 

Dr. José Kennedy Amaral Pereira is a distinguished medical professional specializing in rheumatology, with a strong academic and research background in health sciences. He earned his medical degree from Faculdade de Medicina Estácio de Juazeiro do Norte (2013) and pursued multiple specializations, including Rheumatology and Family Health. Currently, he is completing two master’s programs in Health Sciences and Emergent Technologies in Education. Dr. Pereira has contributed extensively to rheumatology research, particularly in Chikungunya arthritis, publishing in prestigious journals such as Current Rheumatology Reviews and the Yale Journal of Biology and Medicine. He is a member of the editorial board for Current Rheumatology Research and a reviewer for Clinical Rheumatology. His professional experience spans academia and public health, having served as a government-employed physician. Recognized for his contributions, he has received international grants and awards. Dr. Pereira’s work significantly impacts the understanding and management of rheumatic diseases globally.

Professional Profile 

Education

Dr. José Kennedy Amaral Pereira has a diverse and extensive educational background in medicine and health sciences. He earned his medical degree from Faculdade de Medicina Estácio de Juazeiro do Norte in 2013, laying the foundation for his specialization in rheumatology and family health. Further advancing his expertise, he completed postgraduate studies in Rheumatology at the Instituto de Pesquisa e Educação em Saúde de São Paulo (IPES) and Family Health at Universidade Estácio de Sá. Demonstrating a commitment to continuous learning, he is currently pursuing two master’s degrees—one in Health Sciences at Universidade de Pernambuco and another in Emergent Technologies in Education at Must University. His academic journey reflects a multidisciplinary approach, integrating clinical expertise with technological advancements in medical education. Through his rigorous training and research endeavors, Dr. Pereira has established himself as a leading figure in rheumatology, contributing significantly to both patient care and scientific advancements in the field.

Professional Experience

Dr. José Kennedy Amaral Pereira has built a distinguished career in medicine, specializing in rheumatology and family health. With extensive experience in clinical practice, he serves as a rheumatologist at the Hospital das Clínicas in Recife and at Clínica Reumatocare, where he provides expert care for patients with autoimmune and musculoskeletal diseases. His commitment to medical education is evident through his role as a professor at Faculdade Tiradentes in Jaboatão dos Guararapes, where he mentors future healthcare professionals. Additionally, Dr. Pereira contributes to scientific research in health sciences and emerging medical technologies, further enhancing his impact on the field. His dual expertise in clinical practice and academia allows him to bridge the gap between research and patient care, ensuring innovative and evidence-based treatment approaches. Through his dedication to medicine, education, and research, Dr. Pereira continues to make significant contributions to rheumatology and overall healthcare advancements.

Research Interest

Dr. José Kennedy Amaral Pereira’s research interests focus on rheumatology, autoimmune diseases, and innovative treatment approaches in musculoskeletal disorders. His work explores the pathophysiology, diagnosis, and management of conditions such as rheumatoid arthritis, lupus, and spondyloarthritis, aiming to enhance patient outcomes through evidence-based therapies. Additionally, he is deeply engaged in clinical research on biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs), assessing their efficacy and safety in long-term disease control. Dr. Pereira also investigates the role of lifestyle interventions, including diet and exercise, in managing chronic inflammatory conditions. His research extends to family health and primary care, emphasizing the integration of rheumatology into general medical practice. By contributing to medical literature and participating in academic collaborations, he strives to advance knowledge in his field and improve healthcare strategies for patients with rheumatic diseases. His dedication to research underscores his commitment to innovation and excellence in medicine.

Award and Honor

Dr. José Kennedy Amaral Pereira has received numerous awards and honors in recognition of his outstanding contributions to rheumatology and medical research. His dedication to advancing the understanding and treatment of autoimmune and musculoskeletal diseases has earned him prestigious accolades from national and international medical organizations. He has been honored with excellence in research awards for his pioneering work on disease-modifying therapies in rheumatic conditions. Additionally, his contributions to medical education and clinical practice have been recognized through distinguished teaching awards and honorary fellowships from esteemed medical institutions. Dr. Pereira has also received grants and scholarships to support his groundbreaking studies in rheumatology, further solidifying his impact in the field. His active participation in medical conferences as a keynote speaker and his leadership roles in professional societies have garnered widespread recognition. These honors reflect his commitment to innovation, education, and improving patient care in rheumatology.

Research Skill

Dr. José Kennedy Amaral Pereira possesses a diverse and advanced set of research skills that have significantly contributed to the field of rheumatology and autoimmune diseases. His expertise includes clinical trial design, data analysis, and biostatistics, enabling him to conduct rigorous investigations into novel treatment approaches. He is proficient in molecular and immunological techniques, which have allowed him to explore the pathophysiology of rheumatic diseases at a cellular and genetic level. Additionally, his skills in systematic reviews and meta-analyses have provided valuable insights into evidence-based medicine. Dr. Pereira is also well-versed in epidemiological studies, utilizing large-scale patient data to identify disease patterns and treatment outcomes. His ability to integrate translational research with clinical applications has advanced therapeutic strategies for autoimmune disorders. Furthermore, his strong scientific writing and grant-writing abilities have facilitated successful research funding and high-impact publications, reinforcing his leadership in medical research.

Conclusion

José Kennedy Amaral Pereira is a strong candidate for the Best Scholar Award, given his high-impact publications, editorial roles, and contributions to rheumatology research. However, further international collaborations, research diversification, and leadership in academia would further solidify his position as a top contender.

Publications Top Noted

  • Chikungunya Fever and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
    Authors: José Kennedy Amaral, Robert Taylor Schoen, Michael E. Weinblatt, Estelita Lima Cândido
    Year: 2025
    Citation: Tropical Medicine and Infectious Disease, DOI: 10.3390/tropicalmed10020054

  • Bone erosions and joint damage caused by chikungunya virus: a systematic review
    Authors: José Kennedy Amaral, Peter Charles Taylor, Robert Taylor Schoen
    Year: 2024
    Citation: Revista da Sociedade Brasileira de Medicina Tropical, DOI: 10.1590/0037-8682-0433-2023

  • Chikungunya Arthritis Treatment with Methotrexate and Dexamethasone: A Randomized, Double-blind, Placebo-controlled Trial
    Authors: José Kennedy Amaral, Gabriela Lucena, Robert Taylor Schoen
    Year: 2024
    Citation: Current Rheumatology Reviews, DOI: 10.2174/0115733971278715231208114037

  • Quality of Life and Disability in Chikungunya Arthritis
    Authors: José Kennedy Amaral, Peter C. Taylor, Michael E. Weinblatt, Ícaro Bandeira, Robert T. Schoen
    Year: 2024
    Citation: Current Rheumatology Reviews, DOI: 10.2174/1573397119666230726113647

  • Extra-articular Manifestations of Chikungunya
    Authors: Jobson Lopes de Oliveira, Igor Albuquerque Nogueira, J. Kennedy Amaral, Luciana Ribeiro Campos, Mariana Macêdo Militão Mendonça, Marília de Brito Ricarte, Luciano Pamplona de Góes Cavalcanti, Robert T. Schoen
    Year: 2023
    Citation: Revista da Sociedade Brasileira de Medicina Tropical, DOI: 10.1590/0037-8682-0341-2023

  • Pathogenesis of chronic chikungunya arthritis: Resemblances and links with rheumatoid arthritis
    Authors: J. Kennedy Amaral, Clifton O. Bingham III, Peter C. Taylor, Luis M. Vilá, Michael E. Weinblatt, Robert T. Schoen
    Year: 2023
    Citation: Travel Medicine and Infectious Disease, DOI: 10.1016/j.tmaid.2022.102534

 

 

 

E. Foy White-Chu | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. E. Foy White-Chu | Medicine and Dentistry | Best Researcher Award

Geriatrician at OHSU, United States

Dr. E. Foy White-Chu, MD, CWSP, AGSF, is a distinguished geriatrician and wound care specialist at the VA Portland Health Care System (VAPHCS), where she serves as the Geriatric Fellowship Director and Wound Medical Director. She holds an Associate Professorship at Oregon Health & Science University and has extensive experience in geriatrics, wound care, and medical education. Dr. White-Chu has contributed significantly to the field through research, policy initiatives, and curriculum development, securing multiple grants for interdisciplinary wound care education. She has held leadership roles in professional organizations, including the Wound Healing Society and the American Geriatrics Society, and has served on national advisory committees. Her research, focusing on chronic wound care and skin failure in older adults, has been widely published in leading medical journals. Recognized with numerous awards, including Portland’s Top Doctors, she continues to shape healthcare practices through innovation, education, and evidence-based clinical advancements.

Professional Profile 

Education

Dr. E. Foy White-Chu earned her Doctor of Medicine (MD) degree from Baylor College of Medicine, where she developed a strong foundation in geriatric medicine and wound care. She then pursued a residency in Internal Medicine at the University of Texas Southwestern Medical Center, refining her clinical expertise in managing complex medical conditions. Driven by her passion for elderly care, she completed a Geriatrics Fellowship at the University of Texas Health Science Center at San Antonio, gaining specialized training in aging-related health issues, chronic wound care, and interdisciplinary care models. Throughout her education, Dr. White-Chu demonstrated a commitment to academic excellence, research, and medical education, laying the groundwork for her leadership in geriatric medicine. Her advanced training has enabled her to integrate evidence-based practices into clinical care, education, and policy development, contributing significantly to improving healthcare outcomes for older adults, particularly in chronic wound management and skin integrity preservation.

Professional Experience

Dr. E. Foy White-Chu is a distinguished geriatrician with extensive experience in clinical care, research, and medical education. She has held key positions in academic and healthcare institutions, specializing in geriatrics, wound care, and dermatological conditions in older adults. As an attending physician, she has provided expert care for elderly patients, focusing on chronic wound management and skin integrity. Her leadership roles have included faculty appointments where she has mentored medical students, residents, and fellows in geriatric medicine. Dr. White-Chu has contributed significantly to advancing wound care practices, integrating evidence-based approaches into clinical protocols. She has also been actively involved in research, publishing studies on pressure ulcers, dermatological health in aging populations, and best practices for geriatric care. Her dedication extends to policy advocacy, where she works to enhance healthcare standards for older adults. Through her expertise, she continues to shape the future of geriatric medicine and wound care.

Research Interest

Dr. E. Foy White-Chu’s research interests center on geriatrics, dermatology in aging populations, and wound care management. She is particularly focused on pressure ulcers, chronic wound healing, and skin integrity in elderly patients. Her work explores innovative approaches to preventing and treating wounds, emphasizing evidence-based interventions to improve patient outcomes. Dr. White-Chu also investigates the intersection of dermatological health and aging, studying conditions such as xerosis, pruritus, and other skin disorders prevalent in older adults. Additionally, she is committed to advancing geriatric care through research on best practices in long-term care settings, addressing quality-of-life concerns and improving healthcare protocols for aging populations. Her studies contribute to policy development and clinical guidelines, ensuring that older adults receive optimal care. Through her research, she continues to influence advancements in geriatric dermatology and wound management, bridging the gap between medical science and practical healthcare applications for the elderly.

Award and Honor

Dr. E. Foy White-Chu has received numerous awards and honors in recognition of her contributions to geriatrics, dermatology, and wound care management. Her dedication to improving skin integrity in aging populations has earned her accolades from professional medical associations and research institutions. She has been recognized for her excellence in clinical practice, innovative research, and leadership in geriatric healthcare. Dr. White-Chu has received distinguished service awards for her efforts in advancing wound care treatment and pressure ulcer prevention. Additionally, she has been honored for her contributions to medical education, mentoring future healthcare professionals, and enhancing best practices in long-term care settings. Her work has also been acknowledged through invitations to speak at national and international conferences, where she shares her expertise on geriatric dermatology and wound management. Through these honors, Dr. White-Chu’s impact on aging healthcare continues to be recognized and celebrated within the medical community.

Research Skill

Dr. E. Foy White-Chu possesses exceptional research skills, particularly in the fields of geriatrics, dermatology, and wound care. Her expertise lies in conducting clinical studies focused on skin integrity, pressure ulcer prevention, and advanced wound healing techniques in elderly patients. She has a strong background in designing and implementing evidence-based research methodologies, analyzing clinical data, and translating findings into practical healthcare solutions. Dr. White-Chu is skilled in interdisciplinary collaboration, working closely with healthcare professionals, researchers, and policymakers to enhance patient outcomes. Her ability to critically evaluate medical literature and contribute to peer-reviewed publications demonstrates her analytical and scientific writing proficiency. Additionally, she has experience in securing research funding, developing grant proposals, and leading innovative projects in aging-related skin care. Through her rigorous research approach, she continues to advance the understanding of geriatric dermatology, improving the quality of life for elderly individuals with chronic skin conditions.

Conclusion

Dr. E. Foy White-Chu is a highly accomplished researcher in geriatric medicine and wound care, with a strong academic, clinical, and research background. She is well-qualified for the Best Researcher Award, particularly in the domain of geriatric healthcare and wound management. Strengthening international collaborations, expanding research scope to include emerging technologies, and securing larger research grants could further enhance her competitiveness for this prestigious recognition.

Publications Top Noted

Title: Healing a Gap in Medical Education: Efficacy of a Wound Care Didactic Intervention
Authors: Sarah L. Becker, Elizabeth Foy White-Chu, Elena Paz Munoz, Martha A. Oberg, Alex Gerardo Ortega-Loayza
Year: 2025
Citations: 0

Deniz Esin Tekcan Sanli | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Assoc. Prof. Dr. Deniz Esin Tekcan Sanli | Medicine and Dentistry | Best Researcher Award

Faculty Member at Gaziantep University, Faculty of Medicine, Turkey

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı is a distinguished radiologist and researcher specializing in breast imaging, oncological radiology, and artificial intelligence applications in medical diagnostics. Currently serving at Gaziantep University, she holds a European Diploma in Radiology and multiple academic certifications, reflecting her expertise. With a strong research portfolio, she has published extensively in high-impact journals, including the New England Journal of Medicine and Academic Radiology. Her work focuses on improving diagnostic accuracy in breast cancer and exploring advanced imaging techniques. In addition to her medical background, she holds a master’s degree in breast imaging technologies and an associate degree in English translation, showcasing her interdisciplinary skills. Recognized for her contributions to radiology, she continues to advance the field through international collaborations and innovative research. Her commitment to academic excellence and clinical advancements makes her a strong candidate for prestigious research awards in medical science.

Professional Profile

Education

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has a comprehensive educational background in medicine and radiology. She earned her medical degree from Ege University Faculty of Medicine in 2010, followed by a specialization in radiology at Istanbul University Cerrahpaşa Faculty of Medicine, where she conducted research on advanced imaging techniques for Crohn’s disease. She further specialized in breast imaging, completing a thesis-based master’s degree at Acıbadem Mehmet Ali Aydınlar University’s Senology Research Institute, focusing on tumor size correlation in breast cancer. In addition to her medical education, she pursued an associate degree in Applied English and Translation at Istanbul Arel University, demonstrating her interdisciplinary expertise. Her academic achievements are complemented by prestigious certifications, including the European Diploma in Radiology (EDIR) and the Turkish Society of Radiology Proficiency Test (TRD), highlighting her commitment to continuous learning and excellence in radiology.

Professional Experience

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has extensive professional experience in radiology, medical education, and research. She currently serves as an Associate Professor at Gaziantep University, Faculty of Medicine, Department of Radiology, where she contributes to clinical practice, academic teaching, and advanced imaging research. Previously, she worked as an Assistant Professor at both Gaziantep University and Istanbul Rumeli University, gaining experience in medical education and training future healthcare professionals. Her career began as a Research Assistant at Istanbul University Cerrahpaşa Faculty of Medicine, where she conducted specialized research in diagnostic imaging. Over the years, she has earned several professional certifications, including the European Diploma in Radiology (EDIR) and the Interventional Radiology Diploma (TGRD), demonstrating her expertise in both diagnostic and interventional radiology. With a strong publication record and contributions to international collaborations, she continues to make significant advancements in the field of radiology and medical imaging.

Research Interest

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı’s research interests focus on radiology, breast imaging, oncological diagnostics, and artificial intelligence applications in medical imaging. She is particularly dedicated to improving diagnostic accuracy in breast cancer, with research exploring the correlation between radiological and pathological tumor sizes based on molecular subtypes. Her work also extends to advanced imaging techniques for gastrointestinal diseases, as demonstrated by her studies on Crohn’s disease diagnostics. Additionally, she investigates the role of artificial intelligence in early breast cancer detection, aiming to enhance radiological efficiency and reduce unnecessary biopsies. Her interdisciplinary approach, combining medical imaging with AI and statistical modeling, contributes to innovations in diagnostic radiology. Through international collaborations and high-impact publications, she continues to advance the field, striving to improve precision medicine and patient outcomes in oncology and radiology. Her research plays a vital role in shaping future imaging techniques and clinical practices.

Award and Honor

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has received several prestigious awards and honors in recognition of her contributions to radiology and medical research. She holds the European Diploma in Radiology (EDIR), a distinguished certification granted by the European Society of Radiology, highlighting her expertise in diagnostic imaging. She also earned the Interventional Radiology Diploma (TGRD) after successfully completing rigorous training and examinations in Turkey. Additionally, she was awarded the Turkish Society of Radiology Proficiency Test (TRD) Certification, further demonstrating her excellence in the field. Her research has been published in high-impact journals such as the New England Journal of Medicine and Academic Radiology, earning her recognition in the global medical community. Through her dedication to advancing radiology, she continues to contribute to innovative imaging techniques and cancer diagnostics, positioning herself as a leading researcher in her field. Her achievements reflect her commitment to academic and clinical excellence.

Research Skill

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı’s research interests focus on radiology, breast imaging, oncological diagnostics, and artificial intelligence applications in medical imaging. She is particularly dedicated to improving diagnostic accuracy in breast cancer, with research exploring the correlation between radiological and pathological tumor sizes based on molecular subtypes. Her work also extends to advanced imaging techniques for gastrointestinal diseases, as demonstrated by her studies on Crohn’s disease diagnostics. Additionally, she investigates the role of artificial intelligence in early breast cancer detection, aiming to enhance radiological efficiency and reduce unnecessary biopsies. Her interdisciplinary approach, combining medical imaging with AI and statistical modeling, contributes to innovations in diagnostic radiology. Through international collaborations and high-impact publications, she continues to advance the field, striving to improve precision medicine and patient outcomes in oncology and radiology. Her research plays a vital role in shaping future imaging techniques and clinical practices.

Conclusion

Dr. Deniz Esin Tekcan Şanlı is a highly qualified researcher with significant contributions to radiology and oncology, making her a strong candidate for the Best Researcher Award. Her extensive publication record, academic achievements, and interdisciplinary expertise stand out. Strengthening her profile with more leadership roles in major research projects, grant acquisition, and innovation-related contributions would further solidify her candidacy.

Publications Top Noted

  • Gastrointestinal Kaposi’s Sarcoma
    Authors: Deniz Esin Tekcan Şanlı, Şafak Kızıltaş
    Year: 2023
    Citation: New England Journal of Medicine (NEJM), 2023. https://www.nejm.org/doi/pdf/10.1056/NEJMicm2102502

  • Correlation of Radiological and Pathological Tumor Sizes in Breast Cancer Based on Molecular Subtypes and Accompanying DCIS
    Authors: Deniz Esin Tekcan Şanlı, Gül Esen Icten, et al.
    Year: 2025
    Citation: Academic Radiology, https://doi.org/10.1016/j.acra.2025.01.037

  • Artificial Intelligence for Early Detection of Breast Cancer
    Authors: TEKCAN ŞANLI DENİZ ESİN, ALAKUŞ HAKAN
    Year: 2024
    Citation: Die Onkologie, DOI: 10.1007/s00761-024-01654-4

  • Prognostic Factors Affecting Survival of Patients With Single Primary Breast Cancer vs Patients With Multiple Primary Cancers in Lifetime, One of Which is Breast Cancer
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(11):2745-2755. DOI: 10.1177/00031348241248695

  • Should the Breast Cancer Staging System be Revised?
    Authors: Sanli AN, Tekcan Sanli DE, Aydogan F, Altundag MK
    Year: 2024
    Citation: Am Surg., 2024; 90(5):1066-1073. DOI: 10.1177/00031348231223074

  • Is There a Survival Difference Between Male and Female Breast Cancer Subtypes According to the Prognostic Staging System? A Population-Based Cohort Study
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(4):788-799. DOI: 10.1177/00031348231212588

  • Secretory Carcinoma of Breast: A Population-Based Study
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(2):252-260. DOI: 10.1177/00031348231199174

  • Linear Regression Modeling-Based Scoring System to Reduce Benign Breast Biopsies Using Multi-Parametric US with Color Doppler and SWE
    Authors: Erkin Arıbal, Burcu Özdemir, Onur Buğdaycı, Gökhan Ertaş, Deniz E T Şanlı, Handan Kaya
    Year: 2023
    Citation: Academic Radiology, https://doi.org/10.1016/j.acra.2023.01.024

  • Could DTI Unlock the Mystery of Subjective Tinnitus?
    Authors: YILMAZ EREN, YILDIRIM DÜZGÜN, TEKCAN ŞANLI DENİZ ESİN, ELPEN KARYEMEZ FATMA PINAR, et al.
    Year: 2024
    Citation: Indian Journal of Otolaryngology and Head & Neck Surgery, 76, 5277-5284. DOI: 10.1007/s12070-024-04963-7

  • Comparison of Magnetic Seed and RFID Methods in the Localization of Non-Palpable Breast Lesions
    Authors: ŞANLI AHMET NECATİ, TEKCAN ŞANLI DENİZ ESİN, et al.
    Year: 2024
    Citation: Journal of Cancer Research and Therapeutics, 20(5), 1435-1439. DOI: 10.4103/jcrt.jcrt_2253_22

  • CT-Guided Percutaneous Biopsies in the Abdomen and Pelvis
    Authors: TEKCAN ŞANLI DENİZ ESİN, WEBER JEAN PHILIP, MAINTZ DAVID
    Year: 2024
    Citation: Die Onkologie, 30, 875-876. DOI: 10.1007/s00761-024-01576-1

  • Normative Reference Values of Major Thoracic Arterial Vasculature in Turkey
    Authors: Deniz Esin Tekcan Şanlı, Ahmet Necati Şanlı, Onur Yıldırım, Ergin Erginöz, Düzgün Yıldırım
    Year: 2023
    Citation: Northern Clinics of Istanbul, DOI: 10.14744/nci.2021.03206

  • Evaluating Portal Vein and Right Colon Venous Vascular Anatomy and Its Variations via Multidetector CT in Healthy Individuals
    Authors: Uludag, S.S., Kurt, S.A., Sanli, D.E.T. et al.
    Year: 2022
    Citation: Indian Journal of Surgery, 84, 1292–1302. DOI: 10.1007/s12262-022-03583-1

  • CT Findings of the Massive Air Embolism in a Case with Thoracic Gunshot Wound: A Special Case Report as if a Whole Body Pneumo-Angiography was Performed
    Authors: Zeynalova, Amalya; Sanli, Deniz E.T.; Agar, Emir H.; Yildirim, Duzgun; Tuzuner, Filiz
    Year: 2022
    Citation: Current Medical Imaging, 18(11), 1253-1256. DOI: 10.2174/0929866529666220426121222

  • A New Imaging Sign in COVID-19 Pneumonia: Vascular Changes and Their Correlation with Clinical Severity of the Disease
    Authors: Tekcan Şanlı DE, Yıldırım D.
    Year: 2020
    Citation: Diagnostic and Interventional Radiology, DOI: 10.5152/dir.2020.20346

Raj Ramesar | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Prof. Raj Ramesar | Medicine and Dentistry | Best Researcher Award

Director: Research Unit at The University of Cape Town, South Africa

Prof. Raj Ramesar is a distinguished geneticist and researcher specializing in human genetics, genomics, and precision medicine. As Head of the Division of Human Genetics and Director of the MRC Genomics and Precision Medicine Research Unit at the University of Cape Town (UCT), he has made pioneering contributions to understanding the genetic basis of hereditary cancers, particularly familial colorectal cancer. His work has led to advancements in genetic testing, risk assessment, and clinical management, earning international recognition, including the Human Genome Organisation (HUGO) Africa Award and the UCT Vice-Chancellor’s Alan Pifer Award for Research Excellence. Prof. Ramesar has played a key role in developing genomic research infrastructure in Africa, collaborating on global initiatives, supervising numerous PhD theses, and advancing precision medicine applications. His research extends to inherited retinal disorders, contributing to clinical trials for genetic blindness treatments. His leadership continues to shape genomic medicine for public health benefits in Africa and beyond.

Professional Profile 

Education

Prof. Raj Ramesar obtained his academic and professional training in human genetics, laying a strong foundation for his contributions to medical genomics. He earned his Ph.D. in Human Genetics from the University of Cape Town (UCT), where he later became a leading academic and researcher. His postgraduate studies focused on the genetic basis of hereditary cancers and inherited disorders, which positioned him at the forefront of genomic medicine in Africa. Over the years, he has engaged in numerous advanced training programs and international collaborations, enhancing his expertise in precision medicine, genomic research, and bioinformatics. As an educator, he has mentored numerous postgraduate students and played a pivotal role in developing genetic research infrastructure in South Africa. His commitment to education extends beyond the university, as he actively participates in initiatives that promote genetic literacy and capacity-building in Africa. His academic journey reflects a deep commitment to advancing genetic research and education globally.

Professional Experience

Prof. Raj Ramesar is a distinguished geneticist with a career spanning several decades, primarily at the University of Cape Town (UCT). He serves as the Head of the Division of Human Genetics and the Department of Pathology at UCT and its affiliated hospitals.

SAMRC

Prof. Ramesar is also the Director of the South African Medical Research Council’s (SAMRC) Genomic and Precision Medicine Research Unit, where he leads research on the genetic underpinnings of inherited cancers and retinal degenerative disorders.

Institute of Development Management

His work has been instrumental in identifying novel genes and mutations within South African populations, with a recent focus on genetic studies in indigenous African communities. Beyond his research, he contributes to the scientific community by serving on editorial boards of international journals and holding leadership roles, including chairing the board of the Africa Genome Education Institute.

African Scientists

Prof. Ramesar’s professional journey reflects a steadfast commitment to advancing human genetics and improving health outcomes through precision medicine.

Research Interest

Prof. Raj Ramesar’s research interests primarily focus on human genetics, with a strong emphasis on hereditary cancers, inherited disorders, and genomic medicine. His work explores the genetic basis of diseases such as colorectal cancer and retinal dystrophies, aiming to develop early detection strategies and targeted therapies. He is deeply involved in precision medicine, leveraging genomic data to tailor healthcare solutions for diverse populations, particularly in Africa. His research also extends to bioinformatics, gene-environment interactions, and ethical considerations in genetic research. As a leader in African genomics, he is dedicated to addressing health disparities through genetic studies, fostering translational research that bridges the gap between laboratory discoveries and clinical applications. Additionally, he actively contributes to capacity-building initiatives, training researchers and clinicians in genomic methodologies. His work has significant implications for personalized medicine, public health policy, and the integration of genetic research into mainstream healthcare systems.

Award and Honor

Prof. Raj Ramesar, Head of the Division of Human Genetics at the University of Cape Town (UCT), has been honored with several prestigious awards recognizing his significant contributions to human genetics. In 2009, he received the UCT Vice-Chancellor’s Alan Pifer Award for his impactful research.

h3africa.org

In 2015, he was elected to the UCT College of Fellows, acknowledging his exceptional academic achievements.

ResearchGate

The following year, Prof. Ramesar was awarded the inaugural Africa Award by the Human Genome Organisation (HUGO) in recognition of his outstanding contributions to human genetics on the continent.

Health Sciences UCT

More recently, he was nominated for the NSTF-South32 Lifetime Award, further highlighting his enduring impact in the field.

Research Skill

Prof. Raj Ramesar possesses extensive research skills in human genetics, genomic medicine, and molecular biology. His expertise lies in identifying genetic markers associated with inherited diseases, particularly in the African population. He has mastered advanced genomic sequencing techniques, bioinformatics analysis, and molecular diagnostics to uncover genetic predispositions to conditions such as inherited cancers and retinal degenerative disorders. His research involves interdisciplinary collaboration, integrating clinical data with genetic insights to develop precision medicine approaches. Prof. Ramesar is highly skilled in genetic epidemiology, population genetics, and translational research, ensuring that scientific discoveries have practical healthcare applications. His ability to lead large-scale genomic studies, mentor young researchers, and contribute to global genetic research initiatives underscores his scientific acumen. He has also played a pivotal role in establishing genetic research frameworks in South Africa, promoting ethical research practices, and advancing the field of genomic medicine in Africa and beyond.

Conclusion

Dr. Rajkumar Ramesar is highly suitable for the Best Researcher Award. His outstanding contributions to human genetics, leadership in genomic research, and commitment to capacity-building in Africa make him a strong candidate. With his international recognition, innovative research, and dedication to precision medicine, he exemplifies the qualities of an award-winning researcher.

Publications Top Noted

  • Distinct Dysregulated Pathways in Sporadic and Lynch Syndrome‐Associated Colorectal Cancer Offer Insights for Targeted Treatment

    • Authors: May J. Krause, Musalula Sinkala, Raj Ramesar
    • Year: 2025
    • Citation: Krause MJ, Sinkala M, Ramesar R. Distinct Dysregulated Pathways in Sporadic and Lynch Syndrome‐Associated Colorectal Cancer Offer Insights for Targeted Treatment. FEBS Lett. 2025; DOI: 10.1002/1873-3468.70010.

  • Screening of Inherited Retinal Disease Patients in a Low‐Resource Setting Using an Augmented Next‐Generation Sequencing Panel

    • Authors: Nicole Midgley, George Rebello, Lara K. Holtes, Raj Ramesar, Lisa Roberts
    • Year: 2024
    • Citation: Midgley N, Rebello G, Holtes LK, Ramesar R, Roberts L. Screening of Inherited Retinal Disease Patients in a Low‐Resource Setting Using an Augmented Next‐Generation Sequencing Panel. Mol Genet Genomic Med. 2024; DOI: 10.1002/mgg3.70046.

  • Genomic Medicine in the Developing World: Cancer Spectrum, Cumulative Risk and Survival Outcomes for Lynch Syndrome Variant Heterozygotes with Germline Pathogenic Variants in the MLH1 and MSH2 Genes

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ursula Algar, Adam Boutall, Paul Goldberg, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Algar U, Boutall A, Goldberg P, Ramesar R. Genomic Medicine in the Developing World: Cancer Spectrum, Cumulative Risk and Survival Outcomes for Lynch Syndrome Variant Heterozygotes with Germline Pathogenic Variants in the MLH1 and MSH2 Genes. Biomedicines. 2024;12(12):2906. DOI: 10.3390/biomedicines12122906.

  • Influence of Genetic Polymorphisms on the Age at Cancer Diagnosis in a Homogenous Lynch Syndrome Cohort of Individuals Carrying the MLH1:c.1528C>T South African Founder Variant

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Algar U, Goldberg P, Boutall A, Ramesar R. Influence of Genetic Polymorphisms on the Age at Cancer Diagnosis in a Homogenous Lynch Syndrome Cohort of Individuals Carrying the MLH1:c.1528C>T South African Founder Variant. Biomedicines. 2024;12(10):2201. DOI: 10.3390/biomedicines12102201.

  • Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ziyaad Valley-Omar, George Rebello, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Valley-Omar Z, Rebello G, Algar U, Goldberg P, Boutall A, Ramesar R. Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome. J Pers Med. 2024;14(6):575. DOI: 10.3390/jpm14060575.

  • Investigating Somatic Variants and Pathways in Mismatch Repair-Deficient (dMMR) Colorectal Carcinoma in South Africa

    • Authors: Aldera AP, van der Westhuizen J, Tsai W, Krause MJ, Yildiz S, Pillay K, Boutall A, Ramesar R
    • Year: 2024
    • Citation: Aldera AP, van der Westhuizen J, Tsai W, Krause MJ, Yildiz S, Pillay K, Boutall A, Ramesar R. Investigating Somatic Variants and Pathways in Mismatch Repair-Deficient (dMMR) Colorectal Carcinoma in South Africa. J Clin Pathol. 2024; DOI: 10.1136/jcp-2024-209526.

  • Towards Uncovering the Role of Incomplete Penetrance in Maculopathies through Sequencing of 105 Disease-Associated Genes

    • Authors: Hitti-Malin RJ, Panneman DM, Corradi Z, Boonen EGM, Astuti G, Dhaenens CM, Stöhr H, Weber BHF, Sharon D, Banin E, Raj Ramesar, et al.
    • Year: 2024
    • Citation: Hitti-Malin RJ, Panneman DM, Corradi Z, Boonen EGM, Astuti G, Dhaenens CM, Stöhr H, Weber BHF, Sharon D, Banin E, Ramesar R, et al. Towards Uncovering the Role of Incomplete Penetrance in Maculopathies through Sequencing of 105 Disease-Associated Genes. Biomolecules. 2024;14(3):367. DOI: 10.3390/biom14030367.

  • Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ziyaad Valley-Omar, George Rebello, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Valley-O